Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iso-osmolar vs low-osmolar contrast agents in STEMI primary PCI
2008-008491-13Phase 4Completed
- Sponsor
- Azienda USL 8 Arezzo
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iodixanol in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Azienda USL 8 Arezzo. Primary endpoint: Incidence of contrast-induced nephropathy. Started Mar 2009; status: completed.
02
Drugs
iodixanol
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2008-008491-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008491-13.